Investigator Site 1022 — Chicago, Illinois

Investigator Site 1022 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigator Site 1022 has participated in 1 clinical trials.

Therapeutic areas: Hyperkalemia, Resistant Hypertension.

Sponsors: Relypsa, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site 1022?

Investigator Site 1022 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site 1022 conducted?

Investigator Site 1022 has 1 clinical trials on record. Their work covers Hyperkalemia, Resistant Hypertension.

Is Investigator Site 1022 accredited by Crixeo Health?

Investigator Site 1022 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site 1022?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.